Chinese state firm prepares production line for 1 billion COVID-19 vaccine doses
SinoPharm Group, a state-owned Chinese drug manufacturer, is making preparations to be able to supply one billion doses of two potential COVID-19 vaccines that are in late stage trials in 10 countries. The production capacity should be established in 2021. More than 60,000 people have participated in late stage COVID-19 vaccine trials.
Published: October 20, 2020